LMP1 and LMP2A activate the anti-TNF-related apoptosis ligand (TRAIL) activity, stimulate EMT, and promote the maintenance of cancer stem cell (CSC) phenotype, migration, and invasion via the PI3K pathways [219, 220]. This evidence concerns the gene PIK3CA and cancer.